$39.69
0[0.00%]
At close: Apr 25
$39.69
0[0.00%]
PreMarket: 4:00PM EDT
QuidelOrtho
(NASDAQ:QDEL)Latest News for QuidelOrtho Stock (NASDAQ:QDEL)
QuidelOrtho Stock (NASDAQ: QDEL)
Categories: All
Wednesday, April 10, 2024
Tuesday, April 02, 2024
- Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 2, 2024, 1:23PM
- What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?Vandana Singh - Apr 2, 2024, 1:05PM
- QuidelOrtho shares are trading lower. The company announced it will withdraw the current FDA 510(k) submission for its Savanna RVP4+ assay.Benzinga Newsdesk - Apr 2, 2024, 12:29PM
- RBC Out With Note On QuidelOrtho Saying "After Speaking To Management No Change At QuidelOrtho; Company Withdraws Original Savanna RVP4+ Assay From FDA 510(k) Submission, Plans Resubmission Ahead Of 2024/2025 Respiratory SeasonBenzinga Newsdesk - Apr 2, 2024, 12:19PM
- QuidelOrtho Receives FDA Clearance For QuickVue COVID-19 TestBenzinga Newsdesk - Apr 2, 2024, 9:01AM
Wednesday, March 06, 2024
Monday, March 04, 2024
Wednesday, February 21, 2024
Wednesday, February 14, 2024
- Dow Edges Higher; QuidelOrtho Shares PlummetAvi Kapoor - Feb 14, 2024, 2:32PM
- Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?Piero Cingari - Feb 14, 2024, 1:51PM
- Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Feb 14, 2024, 1:18PM
- QuidelOrtho Analysts Cut Their Forecasts After Downbeat ResultsAvi Kapoor - Feb 14, 2024, 12:57PM
- Why Is Diagnostic Maker QuidelOrtho Stock Crashing Wednesday?Vandana Singh - Feb 14, 2024, 12:33PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 14, 2024, 12:31PM
- Craig-Hallum Downgrades QuidelOrtho to HoldBenzinga Newsdesk - Feb 14, 2024, 12:12PM
- Crude Oil Moves Lower; Louisiana-Pacific Posts Upbeat EarningsAvi Kapoor - Feb 14, 2024, 12:08PM
- RBC Capital Maintains Outperform on QuidelOrtho, Lowers Price Target to $81Benzinga Newsdesk - Feb 14, 2024, 10:41AM
- QuidelOrtho shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY24 adjusted EPS below estimates.Benzinga Newsdesk - Feb 14, 2024, 8:48AM
- Raymond James Downgrades QuidelOrtho to Outperform, Lowers Price Target to $76Benzinga Newsdesk - Feb 14, 2024, 8:30AM
- William Blair Downgrades QuidelOrtho to Market PerformBenzinga Newsdesk - Feb 14, 2024, 8:27AM
- Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Feb 14, 2024, 8:12AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Feb 14, 2024, 8:05AM
- US Stocks Priming For Relief Rally After Inflation-Driven Selloff: Strategist Expects To Be Among 'Buyers Of Pullback' Over Next 2-5 DaysShanthi Rexaline - Feb 14, 2024, 7:35AM
- Airbnb Reports Q4 Results, Joins MGM Resorts, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionAvi Kapoor - Feb 14, 2024, 4:55AM
Tuesday, February 13, 2024
- QuidelOrtho shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY24 adjusted EPS below estimates.Benzinga Newsdesk - Feb 13, 2024, 4:36PM
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Feb 13, 2024, 4:31PM
- QuidelOrtho Expects FY24 Total Revenues (Reported) Of $2.76B-$3.07B (Est $2.948B), Adjusted EPS Of $2.40-$3.07 (Est $5.07)Benzinga Newsdesk - Feb 13, 2024, 4:28PM
- Recap: QuidelOrtho Q4 EarningsBenzinga Insights - Feb 13, 2024, 4:10PM
- QuidelOrtho Q4 Adj EPS $1.17 Misses $2.05 Estimate, Sales $742.60M Miss $796.91M EstimateBenzinga Newsdesk - Feb 13, 2024, 4:08PM
- Earnings Scheduled For February 13, 2024Benzinga Insights - Feb 13, 2024, 5:05AM
Monday, February 12, 2024
Thursday, December 21, 2023
Wednesday, December 20, 2023
Monday, December 11, 2023
Thursday, November 16, 2023
Wednesday, November 15, 2023
Thursday, November 02, 2023
Wednesday, November 01, 2023
- QuidelOrtho Maintains FY23 Guidance: Sees Adj. EPS $4.85-$5.30 vs $4.92 Est., Total Revenues $2.88-$3.08 vs $3.02B Est.Benzinga Newsdesk - Nov 1, 2023, 5:00PM
- QuidelOrtho Q3 Adj $0.90 Beats $0.46 Estimate, Sales $744.00M Beat $655.33M EstimateBenzinga Newsdesk - Nov 1, 2023, 4:58PM
- Earnings Scheduled For November 1, 2023Benzinga Insights - Nov 1, 2023, 7:19AM
Thursday, October 12, 2023
- QuidelOrtho shares are trading lower. The company reported preliminary Q3 financial results and reaffirmed FY23 guidance.Benzinga Newsdesk - Oct 12, 2023, 2:35PM
- Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: AnalystVandana Singh - Oct 12, 2023, 12:18PM
- QuidelOrtho Reaffirms FY23 Sales Guidance Of $2.88B-$3.08B Versus Consensus Of $2.98B, With Adjusted EPS Of $4.85-$5.30 Versus Consensus Of $4.90Benzinga Newsdesk - Oct 12, 2023, 7:36AM
- QuidelOrtho Reports Preliminary Q3 Revenues Of $738M-$744M Versus Consensus Of $655.33MBenzinga Newsdesk - Oct 12, 2023, 7:34AM